Beranda › Penyakit Crohn › Georgia › Macon
Uji klinis Penyakit Crohn di Macon, GA
5 studi untuk Penyakit Crohn mencari peserta di lokasi sekitar Macon (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Menerima pesertaFase 3
- Gastroenterology Associates of Central Georgia ( Site 5048), Macon
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Menerima pesertaFase 2
- Gastroenterology Associates of Central Georgia /ID# 280464, Macon
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Menerima pesertaFase 2
- Gastroenterology Associates of Central Georgia /ID# 265547, Macon
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Menerima pesertaFase 3
- Gastroenterology Associates of Central GA, Macon
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Menerima pesertaFase 2/3
- Gastroenterolgy Associates of Central GA, Macon
Uji klinis Penyakit Crohn di kota lain
- New York City, NY35 studi
- Cleveland, OH19 studi
- St. Louis, MO19 studi
- Boston, MA19 studi
- Miami, FL19 studi
- Orlando, FL17 studi
- Houston, TX17 studi
- Atlanta, GA17 studi
- Tyler, TX16 studi
- San Diego, CA15 studi
- San Antonio, TX15 studi
- Los Angeles, CA15 studi
Studi lain di Macon
- Gangguan Somnolen Berlebih5 studi
- Narkolepsi4 studi
- Gangguan Tidur4 studi
- Dermatitis Atopik (Eksim)3 studi
- Diabetes Tipe 23 studi
- Kanker Paru Non-Sel Kecil3 studi
- Penyakit Kardiovaskular3 studi
- Kelelahan3 studi
- Kolitis Ulseratif3 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.